India: 2015's M&A-savvy pharma sector eyes policy changes, robust US market

For the Indian healthcare and pharmaceuticals sector, 2015 was a year of healthy growth driven by mergers and acquisitions, and the bouncing back of domestic market growth. On the other hand, 2016 is seen as a year of hope for further growth boosted by a better US and domestic market, with many policy decisions lined up.